
Indur Life Sciences Private Limited
Manufactures medicinal substances and drugs for pharmaceutical industry.
Manufactures medicinal substances and drugs for pharmaceutical industry.
Indur Life Sciences Private Limited (ILSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 March 2011 and has a history of 14 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Indur Pharma City Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company has closed loans amounting to ₹4.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Muralidhar Rambathri, Hema Rambathri, Gouthami Gankidi, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U45208TG2011PTC073379
073379
Private Limited Indian Non-Government Company
18 Mar 2011
30 Sep 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Muralidhar Rambathri ![]() | Managing Director | 18-Mar-2011 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hema Rambathri ![]() | Director | 25-Feb-2012 | Current |
Gouthami Gankidi ![]() | Additional Director | 17-Mar-2023 | Current |
Raghotham Enakonda ![]() | Director | 08-Oct-2020 | Current |
Ajay Karnavathula ![]() | Additional Director | 23-Mar-2023 | Current |
Indur Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.76% decrease. The company also saw a substantial improvement in profitability, with a 100.27% increase in profit. The company's net worth moved up by a moderate rise of 0.31%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Indur Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Muralidhar Rambathri and Hema Rambathri are mutual person
Gouthami Gankidi is a mutual person
Raghotham Enakonda is a mutual person
₹0
₹4.80 Cr
Date | Lender | Amount | Status |
---|---|---|---|
20 May 2019 | State Bank Of India | ₹4.80 Cr | Satisfied |
Unlock and access historical data on people associated with Indur Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indur Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indur Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 20 May 2019 via Charge ID 100274661 with State Bank Of India was fully satisfied on 28 May 2024.
Indur Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Indur Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ajay Kumar Reddy Karnavathula was appointed as a Additional Director was appointed as a Additional Director on 23 Mar 2023 & has been associated with this company since 2 years 1 month .
Gouthami Gankidi was appointed as a Additional Director was appointed as a Additional Director on 17 Mar 2023 & has been associated with this company since 2 years 1 month .
Raghotham Reddy Enakonda was appointed as a Director was appointed as a Director on 08 Oct 2020 & has been associated with this company since 4 years 6 months .
Indur Life Sciences Private Limited was incorporated on 18 Mar 2011.
The authorized share capital of Indur Life Sciences Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 5.00 Cr.
Currently 5 directors are associated with Indur Life Sciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Indur Life Sciences Private Limited is Plot No. 202 Prestige Park Gundla Pochampally Village Medchal, India, Hyderabad, Telangana, 500014.
The corporate identification number (CIN) of Indur Life Sciences Private Limited is U45208TG2011PTC073379 and the company number is 073379 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Indur Life Sciences Private Limited has fallen by -63.76%.
The financial reports for the fiscal year 2023 indicates that The net worth of Indur Life Sciences Private Limited has experienced an upsurge of 0.31%.
The most recent Balance Sheet for Indur Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
KR
RN
AM
JB